Oarsman Capital Inc. Has $1.50 Million Position in Walgreens Boots Alliance Inc (WBA)

Oarsman Capital Inc. cut its holdings in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 47.6% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 20,653 shares of the pharmacy operator’s stock after selling 18,790 shares during the period. Oarsman Capital Inc.’s holdings in Walgreens Boots Alliance were worth $1,500,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in WBA. Vanguard Group Inc. boosted its holdings in Walgreens Boots Alliance by 2.8% in the 2nd quarter. Vanguard Group Inc. now owns 69,985,653 shares of the pharmacy operator’s stock valued at $5,480,577,000 after purchasing an additional 1,926,108 shares during the period. Franklin Resources Inc. boosted its holdings in Walgreens Boots Alliance by 24.7% in the 2nd quarter. Franklin Resources Inc. now owns 18,502,701 shares of the pharmacy operator’s stock valued at $1,448,939,000 after purchasing an additional 3,662,302 shares during the period. Nordea Investment Management AB boosted its holdings in Walgreens Boots Alliance by 1.0% in the 3rd quarter. Nordea Investment Management AB now owns 10,182,388 shares of the pharmacy operator’s stock valued at $786,284,000 after purchasing an additional 96,552 shares during the period. CI Global Investments Inc. boosted its holdings in Walgreens Boots Alliance by 32.0% in the 4th quarter. CI Global Investments Inc. now owns 7,373,589 shares of the pharmacy operator’s stock valued at $535,470,000 after purchasing an additional 1,785,449 shares during the period. Finally, Dimensional Fund Advisors LP boosted its holdings in Walgreens Boots Alliance by 12.5% in the 3rd quarter. Dimensional Fund Advisors LP now owns 6,641,826 shares of the pharmacy operator’s stock valued at $512,893,000 after purchasing an additional 735,917 shares during the period. 61.57% of the stock is owned by institutional investors.

In other Walgreens Boots Alliance news, insider Stefano Pessina bought 98,858 shares of the firm’s stock in a transaction that occurred on Monday, January 15th. The shares were bought at an average price of $76.07 per share, for a total transaction of $7,520,128.06. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 14.80% of the stock is owned by company insiders.

WBA has been the topic of several research reports. Citigroup lowered their price objective on shares of Walgreens Boots Alliance from $95.00 to $81.00 and set a “buy” rating on the stock in a research report on Thursday, November 2nd. Mizuho set a $94.00 price objective on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Tuesday, October 24th. Jefferies Group set a $93.00 price objective on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Sunday, October 29th. Loop Capital set a $90.00 price objective on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Thursday, October 26th. Finally, Royal Bank of Canada restated a “buy” rating and set a $88.00 price objective on shares of Walgreens Boots Alliance in a research report on Wednesday, October 25th. Ten analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the company’s stock. Walgreens Boots Alliance presently has a consensus rating of “Buy” and an average target price of $85.37.

Walgreens Boots Alliance Inc (WBA) opened at $70.92 on Monday. The company has a market cap of $70,260.00, a price-to-earnings ratio of 19.59, a P/E/G ratio of 1.19 and a beta of 1.18. Walgreens Boots Alliance Inc has a 52-week low of $63.82 and a 52-week high of $88.00. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.96 and a quick ratio of 0.47.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 EPS for the quarter, topping analysts’ consensus estimates of $1.27 by $0.01. The company had revenue of $30.74 billion for the quarter, compared to analysts’ expectations of $30.39 billion. Walgreens Boots Alliance had a net margin of 3.19% and a return on equity of 19.15%. The firm’s revenue was up 7.9% compared to the same quarter last year. During the same quarter last year, the company earned $1.10 EPS. analysts forecast that Walgreens Boots Alliance Inc will post 5.73 earnings per share for the current year.

Walgreens Boots Alliance declared that its board has initiated a share repurchase plan on Wednesday, October 25th that permits the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the pharmacy operator to buy shares of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s management believes its shares are undervalued.

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 12th. Investors of record on Thursday, February 15th will be given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 2.26%. The ex-dividend date of this dividend is Wednesday, February 14th. Walgreens Boots Alliance’s payout ratio is presently 44.20%.

COPYRIGHT VIOLATION NOTICE: This news story was posted by Week Herald and is the property of of Week Herald. If you are viewing this news story on another domain, it was copied illegally and republished in violation of U.S. and international copyright and trademark laws. The correct version of this news story can be read at https://weekherald.com/2018/02/19/oarsman-capital-inc-has-1-50-million-position-in-walgreens-boots-alliance-inc-wba-2.html.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply